• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Sanford Health clinical trial using stem cells reaches full enrollment

Bioengineer.org by Bioengineer.org
January 28, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
David Pearce, Ph.D., executive vice president of innovation and research at Sanford Health

The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one’s own adipose stem cells are used to determine if they can repair partial thickness rotator cuff tears.

Participants will be evaluated for a year. Interim data will be submitted to the FDA at the 6-month mark in November. The FDA then has 30 days to decide whether Phase 2 of the trial can proceed. If so, enrollment in that trial will begin in 2018. Sanford’s Mark Lundeen, M.D., of Fargo and Jason Hurd, M.D., who is based in Sioux Falls, are the study’s principal investigators. Both are orthopedic surgeons.

“Reaching full enrollment in this trial is exciting for Sanford Research and our patients,” said David Pearce, Ph.D., executive vice president of innovation and research at Sanford Health. “We believe in doing everything we can to pioneer and then help develop cutting edge therapies. Research is constantly evolving, and we love being part of that.” [Watch a video explainer of the trial here.]

Adipose-derived stem cells are taken from the patient’s abdominal fat and may help speed up healing or regenerate healthy tissue. This form of therapy is already being used as a standard of care in other countries.

Cell therapy, according to Sanford Health experts, uses the body’s own cells as therapy. Stem cells, in particular, have the ability to repair or regenerate cells that are damaged or killed as the result of injury or disease. Sanford Health’s cell therapy techniques focus on adipose-derived stems cells because they can be used in many parts of the body and are easily collected. Adipose stem cells also yield many times more cells than other sources like bone marrow, can be returned to the body quickly and have a low infection rate.

###

About Sanford Health

Sanford Health is an integrated health system headquartered in the Dakotas. It is one of the largest health systems in the nation with 45 hospitals and nearly 300 clinics in nine states and four countries. Sanford Health’s 28,000 employees, including more than 1,300 physicians, make it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford have allowed for several initiatives, including global children’s clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. For more information, visit sanfordhealth.org.

Media Contact

Jacqueline Palfy
[email protected]
605-366-2432
@sanfordhealth

http://www.sanfordhealth.org

Share12Tweet7Share2ShareShareShare1

Related Posts

Enhancing 3D-Printed Biphasic Scaffolds with Hourglass Design

August 27, 2025

Fluoxetine’s Impact on Weight and Waist Size

August 27, 2025

c-di-GMP Boosts TLR4-Adjuvanted TB Vaccine Efficacy

August 26, 2025

Are Combined EHR Datasets Beneficial for Research?

August 26, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Enhancing 3D-Printed Biphasic Scaffolds with Hourglass Design

Fluoxetine’s Impact on Weight and Waist Size

c-di-GMP Boosts TLR4-Adjuvanted TB Vaccine Efficacy

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.